Reprogramed ipscs isolated from peripheral blood mononuclear cells of patients with MPD5

Ended Purchase Order Awarded Last action

Contract number
75N95022P00361
Awardee
Awarding agency
Obligated
$61,836

Award facts

Opportunity
Contract value 100% obligated
$61,835.75 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541990 All Other Professional, Scientific, and Technical Services
PSC
Q301 Reference Laboratory Testing
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Time and Materials
Place of performance
Camden, NJ 08103, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00002 · Coriell inst for MED research INC:1106625 [22-004990] $0
Funding Only Action P00001 $0
Original award $61,836

Quick answers

Who was awarded contract 75N95022P00361?

75N95022P00361 was awarded to Coriell Institute For Medical Research, Inc. by National Institute on Drug Abuse (National Institutes of Health) on July 22, 2022.

How much is contract 75N95022P00361 worth?

The government has obligated $61,836 on 75N95022P00361.

Was contract 75N95022P00361 competed?

The extent of competition for 75N95022P00361 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award